Biogen Sues Former Partner in Dispute Over Drug Technology Rights

In a legal maneuver that underscores the complexities of pharmaceutical collaborations, Biogen Inc. is taking legal action against a former partner over intellectual property rights concerning a new therapeutic. The dispute arises after Biogen shared developments about an innovative drug under a confidentiality agreement, only to find their Swiss counterpart allegedly making claims over this intellectual property. This issue traces back to a previous partnership that focused on an Alzheimer’s drug, though the drug has since been discontinued. The lawsuit, officially filed on Tuesday, represents Biogen’s efforts to protect its proprietary technologies. For more details on the lawsuit, an article on Law360 provides further insights.